本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atea Pharmaceuticals, Inc.

5.89
+0.590011.13%
盘后5.86-0.0256-0.43%18:44 EST
成交量:146.80万
成交额:820.89万
市值:4.60亿
市盈率:-3.33
高:5.90
开:4.82
低:4.81
收:5.30
52周最高:5.90
52周最低:2.46
股本:7,812.68万
流通股本:6,000.97万
量比:2.19
换手率:2.45%
股息:- -
股息率:- -
每股收益(TTM):-1.7696
每股收益(LYR):-1.9983
净资产收益率:-37.98%
总资产收益率:-23.86%
市净率:1.46
市盈率(LYR):-2.95

数据加载中...

公司资料

公司名字:
Atea Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2012
员工人数:
55
公司地址:
225 Franklin Street,Suite 2100,Boston,Massachusetts,United States
邮编:
02110
电话:
传真:
- -
简介:
Atea Pharmaceuticals, Inc.于2012年7月注册成立,并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司,利用对抗病毒药物开发、药物化学、生物学、生物化学和病毒学的深刻理解,发现和开发新型口服候选产品,以治疗严重的病毒性疾病。

董事

名称
职位
Jean Pierre Sommadossi
President,Chief Executive Officer and Chairman of the Board
Arthur Kirsch
Independent Director
Barbara Duncan
Independent Director
Bruce Polsky
Independent Director
Bruno Lucidi
Independent Director
Franklin Berger
Lead Independent Director
Howard Berman
Independent Director
Jerome Adams
Independent Director
Polly A. Murphy
Independent Director

股东

名称
职位
Jean Pierre Sommadossi
President,Chief Executive Officer and Chairman of the Board
Andrea Corcoran
Chief Financial Officer and Executive Vice President, Legal and Secretary
Janet Hammond
Chief Development Officer
John Vavricka
Chief Commercial Officer
Maria Arantxa Horga
Chief Medical Officer
Wayne Foster
Chief Accounting Officer and Executive Vice President